Kim Kamdar

Biotech Entrepreneur and Investor; Managing Partner, Medical Excellence Capital

Kim Kamdar, Ph.D., is a prominent figure in the life sciences venture capital sector, currently serving as a Managing Partner at Medical Excellence Capital, LLC (MEC). With over 17 years of experience, she has been instrumental in the development of numerous therapeutic startups and companies focused on molecular and companion diagnostics, which are essential for personalized medicine.

Professional Background

Education: Kim obtained her doctorate from Emory University in 1995 and her undergraduate degree from Northwestern University in 1988.
Career Highlights:
- Founding Roles: She was the founding CEO of Truvian Sciences, where she continues to serve as Chair. Additionally, she co-founded Seraphina Therapeutics and has held leadership positions in several other biotech companies including Obalon Therapeutics and Aspen Neuroscience.
- Board Memberships: Kim has served on the boards of various companies such as Syndax Pharmaceuticals, Singular Genomics, and Sera Prognostics, among others.
- Investment Experience: She has been involved with successful exits from companies like Ariosa Diagnostics, sold to Roche for $625 million, and Omniome, which was acquired by Pacific Biosciences for $800 million.

Current Roles

At MEC, Kim focuses on early-stage investments in life sciences and healthcare technology. Her work includes advising on investment strategies and supporting the growth of innovative healthcare solutions. She is also an advisory board member for initiatives like Dr. Eric Topol’s NIH-supported Clinical and Translational Science Award at Scripps Medicine and serves on the investment committee for Adjuvant Capital, a fund backed by the Bill & Melinda Gates Foundation.

Community Involvement

Outside her corporate responsibilities, Kim is engaged in community service through organizations such as Connect San Diego and Access Youth Academy, which aim to empower underserved youth.

Kim Kamdar’s extensive experience and leadership in the biotech field position her as a key player in advancing healthcare innovation through strategic investments and mentorship in emerging companies.